AMDA's Clinical Practice Guideline on Parkinson's Disease in Long-Term Care

Release Date: August 2010
Expiration Date: August 2013

CME Information

Please read the following information before proceeding to the Post-Test and Evaluation Form at the bottom of this webpage.

Target Audience

This CME activity is intended for physicians who practice as medical directors and/or attending physicians as well as consultants, nurse practitioners, and other clinicians in the long term care continuum.

Physicians with current and valid licenses issued by one of the United States, Canadian, or Mexican licensing jurisdictions or who are engaged in residency training in an accredited program in the United States or Canada are eligible for category 1 credit. Physicians licensed in other countries are also welcome to participate in this CME activity. However, the AMA PRA is available only to physicians licensed by the jurisdictions described above and to International members of the AMA.

Participants who review the program, complete the post-test, and receive a score of 80% or higher, can earn CME credit.  Participants who do not receive a score of at least 80% on the post-test are permitted the opportunity to retake the same test one time with no additional fee.

Accreditation Statement

The American Medical Directors Association (AMDA) is accredited by the ACCME to provide continuing medical education to physicians.

Designation Statement

Statement of Need and Learning Objectives

• AMDA members have asked AMDA for ways to participate in self-assessment and self-study CME activities in verbal comments to staff and Education Committee members and in written comments on course evaluation forms.
• AMDA's Education Committee recognizes the need to diversify methods of delivery of CME and recognizes the value of providing distance learning opportunities through enduring materials for self-study.
• Topics and content are determined by ongoing needs assessment by the Clinical Practice and Education Committees using course evaluations, emerging issues in clinical practice, emerging issues in federal and state regulations and survey requirements, a review of the medical literature for long term care, and discussions with peers.

AMDA provides this CME activity with the following learning objectives. By incorporating the information in this CPG into facility specific policies and procedures, practitioners should be able to:

• Recognize patients with Parkinson's Disease who reside in long-term care (LTC) facilities
• Assess patients with Parkinson's Disease who reside in long-term care (LTC) facilities
• Treat patients with Parkinson's Disease who reside in long-term care (LTC) facilities

AMDA Disclaimer Statement

Readers understand that medical and scientific knowledge are constantly evolving. The views and treatment modalities of the authors are their own and may reflect innovations (including off-label or investigational use of medical products) and opinions not universally shared. Every effort has been made to assure the accuracy of the data presented in the context of accepted medical practice. Physicians should check specific details such as drug doses and contraindications, off-label uses, or other details in standard sources prior to clinical application. The views and treatment modalities of the authors are not those of the American Medical Directors Association (AMDA), but are presented in this forum to advance scientific and medical education.

Disclosures:

Planning Committee
Ms. Sheena Majette, AMDA Director of Education has no relevant financial relationships to disclose.
Ms. Jacqueline Vance, RN-C, CDONA has no relevant financial relationships to disclose.

Test Writer
Ms. Jennifer Holmes has no relevant financial relationships to disclose.

You must complete the entire test and evaluation below to claim credits for this CME activity.